Using enzymatic assay and radioimmunoassay, we studied the functional
status of pancreatic islet in 50 patients with acute leukemia. Oral gl
ucose tolerance test and insulin and C peptide release were made in 40
patients before and after treatment. 14 patients who revealed diabeti
c curve and delayed insulin and C peptide release before treatment sho
wed normal values in 6 after therapy. Five patients with impaired gluc
ose tolerance and decreased insulin and C peptide release before treat
ment showed normalization of these parameters following therapy. Five
patients with normal pretreatment values disclosed abnormal post-treat
ment results. The remaining 16 patients displayed normal results both
before sind after therapy. Anti-insulin antibodies were negative, and
glucagon level was normal in ah the 50 patients. The red fell insulin
receptor binding rate analysed in 47 patients was significantly higher
than in controls (P<0.001). We considered that the disturbed glucose
metabolism in acute leukemia was not uncommon mainly due to the dysfun
ction of pancreatic islet beta cells as a result of islet damage by le
ukemic cells, the effect of corticosteroid and chemotherapy and the pr
eexisting diabetes. Impaired glucose metabolism had no influence on th
erapeutic effect.